Anteris Technologies Global Corp

AVRNASDAQ · USD
5.09USD0.00 (-2.31%)
137

Anteris Technologies Global Corp (AVR) Covered Calls

Read more

Running AVR covered calls helps you generate income from Anteris Technologies Global Corp shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best AVR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If AVR stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling AVR covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given AVR covered call is worth writing.

Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta.

2026-12-18317.5040.980.050.30223.0041.92493.54-0.94+0.20610.25
2027-02-19947.5040.980.050.85223.0041.92162.76-0.94+0.33620.80
2027-05-211857.5040.980.251.25243.0045.6890.12-4.70+0.42431.00

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank—
  • Market cap (M$)496
  • 52 weeks high-53.98%
  • 52 weeks low54.24%
  • Analyst recommendationBuy
    1.83
  • Target price$12.64
    148.33% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-10
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.60
  • EPS growth next 5 years26.82%

As of Nov 19, 2026